|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02096 SIMCERE PHARMA
Nominal 
6.780 +0.140 (+2.108%) | 2024/06 - Interim RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 151,048 | 1,354,099 | (201,970) | 96,731 |
| Net Cash from / (used in) Investing Activities | -- | 1,087,807 | 68,306 | (435,503) | 529,083 |
| Net Cash from / (used in) Financing Activities | -- | (894,834) | (753,681) | (1,624,531) | 2,353,622 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | 344,021 | 668,724 | (2,262,004) | 2,979,436 |
| Cash & Cash Equivalents at beginning of period | -- | 1,658,312 | 974,464 | 3,270,241 | 354,804 |
| Effect of Foreign Exchange Rate Changes | -- | 4,829 | 15,124 | (35,098) | (63,999) |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 2,007,162 | 1,658,312 | 973,139 | 3,270,241 |
| Remarks: | Real time quote last updated: 24/12/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 456,600 |
| %Change | -79.918% |
| EPS / (LPS) | RMB 0.180 |
| NBV Per Share (¥) | RMB 2.716 |